Nerve Growth Factor for the Treatment of Cornea Disease

Status Completed

Clinical Trial Summary

To determine the efficacy and safety of nerve growth factor in the treatment of limbal stem cell deficiency (LSCD) associated with neurotrophic cornea.

Clinical Trial Description

This is a prospective open-label pilot study evaluating the role of cenegermin-bkbj for the treatment of LSCD with associated neurotrophic keratopathy. Patient diagnosed with LSCD with neurotrophic cornea who have failed conventional treatment such as artificial tears are enrolled in the study after a 2 week washout period. Patient are then treated with cenegermin-bkbj over an 8 week period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04552730
Study type	Observational
Source	Stanford University
Contact
Status	Completed
Phase
Start date	October 14, 2020
Completion date	May 4, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04485546` - Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis	Phase 4
Not yet recruiting	`NCT05927428` - Assessment of the Safety and Efficacy of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis	Phase 2
Completed	`NCT04276558` - REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients	Phase 2
Recruiting	`NCT04573647` - OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
Completed	`NCT04820010` - Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
Recruiting	`NCT04627571` - Corneal Nerves After Treatment With Cenegermin
Enrolling by invitation	`NCT05758753` - QST for Corneal Nerve Function	N/A
Terminated	`NCT05809245` - Corneal Neurotization as a Treatment for Neurotrophic Keratopathy	N/A
Withdrawn	`NCT05321251` - Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.	Phase 2/Phase 3
Terminated	`NCT03037450` - Miniinvasive Corneal Neurotization. A Pilot Study.	N/A
Not yet recruiting	`NCT06364657` - Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
Recruiting	`NCT05566717` - An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity
Not yet recruiting	`NCT02707120` - Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis	Phase 4
Completed	`NCT01756456` - Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.	Phase 1/Phase 2
Completed	`NCT02227147` - Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK	Phase 2
Recruiting	`NCT05552261` - DEFENDO Long Term Follow-up Study in Stage 1 NK Patients
Recruiting	`NCT04909450` - Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects	Phase 1/Phase 2
Active, not recruiting	`NCT06411145` - Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis	Phase 4